Maria Rosaria Ricciardi Selected Research

mirdametinib

8/2009

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Rosaria Ricciardi Research Topics

Disease

17	Multiple Myeloma 11/2020 - 12/2002
16	Neoplasms (Cancer) 11/2019 - 12/2002
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 03/2007
3	Hematologic Neoplasms (Hematological Malignancy) 11/2020 - 10/2015
3	Melanoma (Melanoma, Malignant) 01/2019 - 08/2009
3	Leukemia 08/2018 - 10/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2015 - 05/2007
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2013 - 08/2008
1	Obesity 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Immune Reconstitution Inflammatory Syndrome 01/2020
1	Pancytopenia 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2018
1	Vitiligo 10/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2009
1	Disease Progression 08/2008
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2007
1	Acute Promyelocytic Leukemia 03/2007

Drug/Important Bio-Agent (IBA)

10	LigandsIBA 01/2019 - 04/2009
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 10/2015
4	micaIBA 01/2019 - 06/2013
4	Pharmaceutical PreparationsIBA 01/2018 - 04/2009
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2012 - 03/2007
3	Phosphotransferases (Kinase)IBA 10/2017 - 12/2015
2	NF-kappa B (NF-kB)IBA 02/2020 - 01/2017
2	Immunomodulating AgentsIBA 11/2019 - 09/2015
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 04/2018
2	Adenosine Triphosphate (ATP)IBA 10/2017 - 01/2012
2	CytokinesIBA 01/2017 - 12/2016
2	NVP-BKM120IBA 02/2016 - 12/2015
1	ChromatinIBA 11/2020
1	Monoclonal AntibodiesIBA 11/2020
1	Interleukin-8 (Interleukin 8)IBA 02/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2019
1	Transcription Factors (Transcription Factor)IBA 11/2019
1	Ligases (Synthetase)IBA 11/2019
1	CholesterolIBA 01/2019
1	Liver X ReceptorsIBA 01/2019
1	MTOR InhibitorsIBA 08/2018
1	Biological ProductsIBA 08/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	Cardiolipins (Cardiolipin)IBA 10/2017
1	Protons (Proton)IBA 10/2017
1	Oxidoreductases (Dehydrogenase)IBA 10/2017
1	EnzymesIBA 10/2017
1	HexokinaseIBA 10/2017
1	p38 Mitogen-Activated Protein KinasesIBA 01/2017
1	Vincristine (Oncovin)FDA LinkGeneric 01/2017
1	Melphalan (Alkeran)FDA LinkGeneric 01/2017
1	UbiquitinIBA 01/2017
1	Glycogen Synthase Kinase 3IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Chemokine ReceptorsIBA 11/2015
1	ChemokinesIBA 11/2015
1	CarbonIBA 10/2015
1	Carnitine (L-Carnitine)FDA LinkGeneric 10/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2015
1	ST1326IBA 10/2015
1	TransferasesIBA 10/2015
1	A-factor (Streptomyces)IBA 06/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2013
1	Glycogen Synthase (Synthase I)IBA 06/2013
1	poliovirus receptorIBA 06/2013
1	Immunoglobulin D (IgD)IBA 04/2013
1	TOR Serine-Threonine KinasesIBA 06/2012
1	Uridine Triphosphate (UTP)IBA 01/2012
1	Zoledronic Acid (Zometa)FDA Link 01/2010
1	Bortezomib (Velcade)FDA Link 01/2010
1	mirdametinibIBA 08/2009
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 04/2009
1	Caffeine (No Doz)FDA LinkGeneric 04/2009
1	Immunoglobulin M (IgM)IBA 08/2008
1	Cytotoxins (Cytolysins)IBA 06/2007
1	Drug CombinationsIBA 06/2007
1	OligonucleotidesIBA 05/2007
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 03/2007
1	RetinoidsIBA 03/2007
1	Interleukin-6 (Interleukin 6)IBA 12/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2002

Therapy/Procedure

7	Therapeutics 01/2021 - 06/2007
2	Drug Therapy (Chemotherapy) 12/2016 - 07/2014
2	Ligation 08/2008 - 03/2007
1	Stem Cell Transplantation 01/2020
1	Aftercare (After-Treatment) 04/2009